KM Biotech, Inc.
Records under this name other than the patents KM Biotech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 7 of 7 · Back to KM Biotech, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,795,215 | MNTF peptides and compositions and methods of use Term ended Term ended May 24, 2025 · From the USPTO record | Term ended | Term ended May 24, 2025 | From the USPTO record |
| US 7,183,373 | MNTF peptides and compositions and methods of use Term ended Term ended Jan 21, 2024 · From the USPTO record | Term ended | Term ended Jan 21, 2024 | From the USPTO record |
| US 8,986,676 | MNTF differentiation and growth of stem cells Lapsed on the fee record Ended Mar 24, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 24, 2023 | From the USPTO record |
| US 6,759,389 | Motoneuronotrophic factors Formerly held Term ended Term ended Oct 4, 2017 · From the USPTO record | Term ended | Term ended Oct 4, 2017 | From the USPTO record |
| US 6,309,877 | Polynucleotides encoding motoneuronotrophic factors Formerly held Term ended Term ended Sep 12, 2017 · From the USPTO record | Term ended | Term ended Sep 12, 2017 | From the USPTO record |
| US 6,147,052 | Method of differentiating erythrocyte progenitor cells Term ended Term ended Aug 29, 2017 · From the USPTO record | Term ended | Term ended Aug 29, 2017 | From the USPTO record |
| US 6,841,531 | Methods and use of motoneuronotrophic factors Formerly held Term ended Term ended Jan 11, 2017 · From the USPTO record | Term ended | Term ended Jan 11, 2017 | From the USPTO record |